- Valuating environmental impacts of genetically modified crops – ecological and ethical criteria for regulatory decision-making (VERDI)
- Buchreihe: Nationales Forschungsprogramm "Nutzen und Risiken der Freisetzung gentechnisch veränderter Pflanzen" (NFP 59)
- Auflage: 1., 2012
- Seiten: 192 Seiten
- Abbildungen: zahlreiche Abbildungen und Tabellen
- Format in cm: 17,0 x 24,0
- Einbandart: PDF
- ISBN: 978-3-7281-3464-6
- DOI: 10.3218/3464-6
- Sprache: Englisch
- Lieferstatus: gedruckte Ausgabe vergriffen, als eBook (Open Access) erhältlich
Genetic Engineering, GM Crops, Biodiversity, Bioethics, Biosafety
The debate on the possible impact of genetically modified (GM) crops on biodiversity shows that so far there is no consensus on generally accepted assessment criteria for environmental harm. This debate stems primarily not from a shortage of data, but rather from the absence of criteria for assessing the effects of GM plants on biodiversity. Since there are no exact assessment criteria, regulatory decision-making processes are often not transparent and can be difficult to understand. This increases the danger that decisions on environmental risks from GM plants may appear arbitrary.
The VERDI Project (Valuating environmental impacts of genetically modified crops – ecological and ethical criteria for regulatory decision-making) is a interdisciplinary collaboration between biosafety experts and risk ethicists. Its aim is to develop recommendations for decision makers and regulatory authorities, thus helping to improve the regulation of GM plants. The results show that both the unambiguous description of protection goals and the establishment of a basis of comparison are two essential criteria when defining harm.
The book presents a proposal how criteria for the evaluation of GM crops could be developed. The book is directed to all those involved in the debate on benefits and risks of genetic engineering, in particular to decision-makers and regulatory authorities, but also to scientists from academia and the agricultural biotechnology industry.
Target audience: decision-makers from policy, authorities and science
(Donations only possible with PayPal Account)